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Evaluation of pancreatin stability through enzyme 
activity determination
Pancreatin is a biotechnological product containing an en-
zyme complex, obtained from porcine pancreas, that is em-
ployed in treating pancreatic diseases. Experiments re-
garding the stability of the pharmaceutical formulation 
containing pancreatin were performed using standard bi-
nary mixtures with 6 excipients in a 1:1 ratio (m/m) and a 
commercial formulation. To accomplish these goals, sam-
ples were stored for 1, 3 and 6 months at 40 ± 1 °C and 75 ± 
5 % relative humidity (RH) and 40 ± 1 °C and 0 % RH. Stress 
testing was also performed. All samples were analyzed to 
evaluate the α-amylase, lipase and protease activities 
through UV/Vis spectrophotometry. The results revealed 
that the excipient proprieties and the storage conditions af-
fected enzyme stability. Humidity was a strong influencing 
factor in the reduction of α-amylase and protease activities. 
Stress testing indicated that pH 9.0 and UV light did not 
induce substantial alterations in enzyme activity. 
Keywords: α-amylase, lipase, protease, stress testing, pancrea-
tin stability, biopharmaceutical, UV/VIS spectrophotometry
Stability of pharmaceutical products depends on various factors, including environ-
mental factors (e.g., temperature, humidity and light) and other factors related to the product 
itself, such as the physicochemical properties of active substances and pharmaceutical 
excipients, the shape and composition of the pharmaceutical, the fabrication process, and 
the type and properties of packaging materials (1).
For pharmaceutical products, the stability of biopharmaceuticals could require spe-
cial attention because of their inherent physicochemical complexity. In this sense, stability 
tests are performed to determine the expiration date, the utilization period and the storage 
conditions. During the various fabrication stages of these biopharmaceuticals, aggregates 
and degradation products might form and compromise the stability, quality and security 
of the formulations (2).
Pancreatin is a biopharmaceutical obtained from swine pancreas, and according to 
the United State Pharmacopoeia, it is defined as a substance that contains enzymes, mainly 
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α-amylase, lipase and protease that show pharmaceutical importance as therapeutic agents 
in acute and chronic pancreatitis (3).
There are few studies (2, 4) related to the enzyme activity of the pancreatin complex. 
Thus, the main objective of the present study was to evaluate the stability of formulations 
containing pancreatin. For this purposes, experiments using standard pancreatin and its 
binary mixtures with different excipients (ratio of 1:1, m/m) were performed. In addition, 
the stability of the commercial formulation containing pancreatin was evaluated. Stress 
testing was also performed on pancreatin.
The activities of the three enzymes (α-amylase, lipase and protease) in all samples 
were analyzed through spectrophotometric tests, recommended by the ICH Q5C guide-
lines (5), which include elaborate guidelines concerning assays to determine the quality of 
biological and biotechnological products.
EXPERIMENTAL
Samples
The influence of excipients and storage conditions on enzyme stability was deter-
mined for samples of standard pancreatin (Sigma-Aldrich, USA), the commercial formula-
tion and binary mixtures of standard pancreatin with each excipient (citric acid, magne-
sium stearate, mannitol, microcrystalline cellulose, sucrose and talc) at a 1:1 ratio (m/m). 
The excipients (99 % degree of purity) were provided by Aché Laboratórios Farmacêuticos 
S.A. Stress testing analysis was only performed for standard pancreatin. 
Stability condition
Samples were stored under the conditions recommended by ICH in a stability chamber 
for 1-, 3- and 6-month periods at 40 ± 1 °C and 75 ± 5 % relative humidity (RH) and at 40 ± 1 °C 
in the absence of humidity (5). 
Preparation of standard pancreatin and binary mixtures
Binary mixtures at a 1:1 ratio (m/m) were prepared with 30 mg of standard pancreatin 
and 30 mg of each excipient in a polyethylene container (3 cm height × 2 cm diameter). The 
samples were homogenized by vortexing for 1 min, and stainless steel balls (2 mm diam-
eter) were used to mix the samples. In addition, 30 mg of standard pancreatin was placed 
in a polyethylene container. All samples were prepared in triplicate.
After the storage time, all samples were solubilized in 25 mL of TRIS + HCl buffer 
(50 mmol L–1, pH 7.0) and a stock solution containing 90 U mL–1 α-amylase, 7.2 U mL–1 li-
pase and 90 U mL–1 protease was obtained. These concentrations were estimated from the 
specification of the standard pancreatin manufacturer, which indicated that 1 mg of stan-
dard pancreatin contained 75.0 U amylase, 6.0 U lipase and 75.0 U protease.
For α-amylase activity determination, a new dilution was prepared using TRIS + HCl 
buffer (50 mmol L–1, pH 7.0) and a solution of 2.0 U mL–1 α-amylase was obtained. For lipase, 
TRIS + HCl buffer (50 mmol L–1, pH 9.0) was used and a solution containing 6.0 U mL–1 of 
this enzyme was obtained. Finally, TRIS + HCl buffer (50 mmol L–1, pH 7.5) was used to 
obtain a solution of 14.0 U mL–1 protease.
425
G. de Paula Terra et al.: Evaluation of pancreatin stability through enzyme activity determination, Acta Pharm. 66 (2016) 423–431.
 
Preparation of commercial formulation 
Commercial formulation samples (both whole capsules and the internal powder con-
tent) were evaluated. To obtain the powder from the commercial formulation, capsules 
were opened, the contents were transferred to a mortar and the material was ground and 
homogenized. The average mass of each capsule was 258 ± 10 mg. According to the label 
information, each capsule contained 33,200, 10,000 and 37,500 U of α-amylase, lipase and 
protease, respectively. Then, the enzymes available in 30 mg of homogenized powder were 
solubilized in TRIS + HCl buffer (pH 7.0) to prepare a solution containing 153.0 U mL–1 
α-amylase, 46.0 U mL–1 lipase and 173.0 U mL–1 protease. From this solution, three further 
dilutions were made using TRIS + HCl buffer to obtain solutions of 2.0 U mL–1 α-amylase, 
6.0 U mL–1 lipase and 14.0 U mL–1 protease.
Stress testing
A stress test was performed as recommended by ICH (5). In this case, five conditions 
were applied: high temperature, acidic pH, basic pH, ultraviolet light and forced oxidation. 
The analyses were conducted according to the procedures described by Blessy et al. and 
Printz et al. (6, 7). Briefly, 2.5 mg of standard pancreatin was weighed and then solubilized 
in TRIS + HCl buffer (50 mmol L–1, pH 7.0). Such solutions of standard pancreatin, having 
a final volume of 1.0 mL, were prepared in 1.5-mL microtubes. After solubilization, the 
solutions were centrifuged for 1 minute at 1,000 rpm and then placed in an ultrasound 
bath. In the prepared samples, the activities were 187.5, 15.0 and 187.5 U mL–1 for a-amylase, 
lipase and protease, respectively.
For thermal stability testing, the solution containing pancreatin was subjected to 
70 °C for 60 minutes in a water bath and then cooled to room temperature. The choice of 
temperature was based on the optimal temperature for pancreatin activity (70 °C induces 
degradation of all enzymes in the pancreatin complex) (8).
To test the pH influence, pancreatin samples were subjected to acid (100 mmol L–1 
citric acid buffer, pH 3.0) and base (100 mmol L–1 TRIS + HCl buffer, pH 9.0 and 50 mmol L–1 
carbonate/bicarbonate buffer, pH 11.0). Activity tests were performed after 60 minutes of 
exposure. The applied pH conditions had the objective of providing forced degradation 
conditions and were selected according to the optimal activity pH of the main pancreatin 
enzymes.
The solution of pancreatin was exposed to a photostability chamber with 1.2 million 
lux-hours of ultraviolet light at 25 °C for stress tests. Such samples were stored in amber 
vials and under refrigeration at 4 °C until analysis. Finally, pancreatin solutions were pre-
pared in 50 mmol L–1 TRIS+HCl buffer, pH 7.0, and 3 % (v/v) hydrogen peroxide for forced 
oxidation. All of stress tests were performed in triplicate and samples were analyzed for 
activity as soon as the tests were completed. 
Spectrophotometric analyses
Spectrophotometric analyses were performed using a spectrophotometer (UV-Vis 
1800, Shimadzu, Japan). In these analyses, the limit of quantification (LOQ) was calculated 
as 10 times the ratio between the standard deviation of the blank and the slope of the re-
spective calibration curve.
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a-amylase. – The method was based on the measurement of amylolytic activity through 
quantification of the reducing sugars given off by the starch hydrolysis reaction, catalyzed 
by amylases. The reducing sugars were quantified at 550 nm. The α-amylase activity was 
determined based on the methodology described by ANVISA and Russel (9, 10).
Lipase. – The lipase activity was determined through quantification of the product 
formed by the lipase-catalyzed hydrolysis of p-nitrophenyl palmitate. The chromogen 
product was quantified at 410 nm. The lipase activity analyses were performed based on 
the method described by Kanwar (11) and Abd-Elhakeem (12).
Protease. – The proteolytic activity was determined by quantification of the azo com-
pound released during the hydrolysis of the chromogenic substrate azocasein. The 
 protease activity was determined at 400 nm based on the methodology described by 
 ANVISA (9).
RESULTS AND DISCUSSION
Each enzyme of the pancreatin complex showed a different degradation profile, which 
was strongly influenced by distinct storage conditions. This profile could be accompanied 
by changes as a function of time (initial, 1-, 3- and 6-months), allowing a detailed analysis 
of the behavior of enzyme activities during storage. 
In stability analyses, one hundred % of the activity of each enzyme was assumed from 
the absorbance obtained from the standard pancreatin solution containing 2.0 U mL–1 
α-amylase, 6.0 U mL–1 lipase, and 14.0 U mL–1 protease.
Stability of α-amylase
When stored at 40 °C and 75 % RH (Table I), a total decline in activity of this enzyme 
was observed in just one month when the pancreatin was stored in the absence and pres-
ence of all excipients. This finding shows that humidity exerts a strong influence on 
α-amylase stability, inducing its degradation. Thus, none of the evaluated excipients was 
able to provide a protective effect for α-amylase. In the commercial formulation sample, 
the activity (only 12.5 % of activity was found both in the capsule and powder) decreased 
considerably, showing that the combination of temperature and humidity exerts a strong 
negative influence on α-amylase stability, inducing a distortion of the enzyme structure. 
The same profile was observed when the commercial formulation was analyzed after 3 
months.
When α-amylase was analyzed after 1 month of storage at 40 °C and 0 % RH (Table I), 
its activity was 61.0 % of the activity when pancreatin was stored without excipients. How-
ever, sucrose and mannitol showed protective effects on α-amylase activities (79.5 and 68.0 %, 
respectively). The other excipients did not provide effective protection. After 3 months, 
α-amylase activities were low in all samples. However, sucrose still showed a protective ef-
fect on this enzyme, maintaining its activity at 52.0 %. After 6 months, a-amylase showed 
activity lower than the LOQ for the pancreatin standard stored without excipients. In the 
commercial formulation sample, higher preservation of activity was observed compared to 
that for the samples stored with humidity. 
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Stability of lipase
Lipase had a very similar stability profile under both conditions; this enzyme showed 
higher activity levels in binary mixtures and the pancreatin standard. After 1 month at 
40 °C and 75 % RH (Table II), lipase showed activity of 66.3 ± 0.9 % in the absence of ex-
cipients. The only excipient that showed a protective effect was sucrose, which maintained 
the enzymatic activity at 88.7 ± 0.9 %. The other excipients (citric acid, mannitol, cellulose, 
magnesium stearate and talc) led to lower enzymatic activity than the activity of standard 
pancreatin. After 6 months, the mixtures with mannitol, magnesium stearate and talc 
showed a decrease in lipase activity (LOQ £ 3.3 %).
In the commercial formulation samples, a drastic decrease in lipase activity was ob-
served for the storage at 40 °C and 75 % RH, further demonstrating that humidity exerts a 
strong negative influence on enzyme structure. This finding indicates that the effective-
ness of the commercial formulation is compromised under such conditions.
In contrast to the results for humidity conditions, sucrose did not show a protective 
effect on lipase activity. Independently of incubation time, samples with magnesium stea-
rate stored at 40 °C and 0 % RH showed the highest lipase activities compared to the stan-
dard pancreatin sample. The magnesium stearate effect on lipase activity is interesting and 
could be attributed to enzyme affinity for hydrophobic excipients, such as stearate, which 
interact with the enzyme active site and reduce its three-dimensional distortion (13). When 
lipase activities were determined for the commercial formulation after 1 month, there was 
better preservation of this enzyme (75 and 64 % in the capsule and powder, respectively). 
After 3 months, a low level of activity was observed (14.5 and 16.3 % in the same previ-
Table I. Activity of α-amylase (%) in pancreatin samples stored at 40 °C and 75 % RH and 40 °C and 0 % RH 
after different times of incubationa
Sample Initial value
With humidity No humidity
1-month 3-months 6-months 1-month 3-months 6-months
Pancreatin 98.3 ± 0.9 £ LOQ £ LOQ £ LOQ 61.0 ± 0.7 33.0 ± 0.7 £ LOQ
P + citric acid 99.1 ± 0.9 £ LOQ £ LOQ £ LOQ 13.3 ± 0.5 £ LOQ £ LOQ
P + sacharose 97.6 ± 0.9 £ LOQ £ LOQ £ LOQ 79.5 ± 0.9 52.0 ± 0.7 11.0 ± 0.8
P + mannitol 98.7 ± 1.1 £ LOQ £ LOQ £ LOQ 68.0 ± 0.6 33.0 ± 0.6 4.5 ± 0.5
P + cellulose 98.4 ± 1.3 £ LOQ £ LOQ £ LOQ 2.5 ± 0.1 £ LOQ £ LOQ
P +  Mg-stearate 99.5 ± 1.1 £ LOQ £ LOQ £ LOQ 43.5 ± 0.7 17.5 ± 0.6 4.5 ± 0.5
P + talc 98.1 ± 1.2 £ LOQ £ LOQ £ LOQ 17.0 ± 0.7 4.5 ± 0.3 £ LOQ
Capsule 92.5 ± 0.6 12.5 ± 0.4 5.7 ± 0.6 – 69.0 ± 0.7 26.6 ± 0.8 –
Powder 90.2 ± 0.4 12.5 ± 0.3 3.2 ± 0.5 – 55.0 ± 0.6 23.5 ± 0.7 –
P – Pancreatin standard
a Mean ± SD, n = 3.
b £ LOQ – 2.2 % of activity.
c Period of storage not evaluated.
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ously mentioned samples). Further, in this case, the capsules did not have an adequate 
protective effect on the active pharmaceutical ingredient.
Stability of protease
After 1 month at 40 °C and 75 % RH (Table III), the protease activity in the pancreatin 
standard decreased considerably (only 8.3 ± 0.5 % of the activity was detected). Sucrose 
and cellulose did not significantly affect the protease activity (no significant differences 
were found after applying the t-test at the 95 % confidence level for comparison with stan-
dard pancreatin). This effect is likely due to the chiral centers of enzymes (14). The pres-
ence of mannitol, magnesium stearate and talc further decreased protease activities. How-
ever, citric acid increased the protease activity to approximately two times the value of 
pure standard pancreatin. Thus, citric acid exerted a protective effect under conditions of 
humidity storage. In the commercial formulation, the detected activity was 77.9 and 48.4 % 
in the capsule and powder, respectively.
When this enzyme was analyzed after 1 month at 40 °C and 0 % RH (Table III), a total 
decrease in activity was observed in the pancreatin standard (LOQ £ 2.6 %). The same 
behavior was observed when the sample was mixed with citric acid. However, some ex-
cipients, such as cellulose and talc, showed a slight protective effect. After 3 and 6 months, 
a total decrease in protease activity was observed for both storage conditions. Amino acid 
residues (mainly cysteine) can interfere with enzyme activity. These structures are likely 
to combine with essential amino acids, thus decreasing the enzyme conformational stabil-
ity and consequently reducing its activity (15). 
Table II. Activity of lipase (%) in pancreatin samples stored at 40 °C and 75 % RH and 40 °C and 0 % RH after 
different times of incubationa
Sample Initial value
With humidity No humidity
1-month 3-months 6-months 1-month 3-months 6-months
Pancreatin 100.0 ± 0.2 66.3 ± 0.9 24.4 ± 0.7 7.6 ± 0.6 60.6 ± 0.5 21.0 ± 0.9 7.6 ± 0.6
P + citric acid 97.7 ± 0.2 24.9 ± 0.7 9.6 ± 0.7 £ LOQ 43.6 ± 0.5 15.0 ± 0.5 2.8 ± 0.4
P + sacharose 99.3 ± 0.7 88.7 ± 0.9 50.1 ± 0.4 15.0 ± 0.9 29.7 ± 0.7 12.7 ± 0.9 3.4 ± 0.6
P + mannitol 98.2 ± 0.4 27.5 ± 0.2 7.4 ± 0.4 £ LOQ 24.9 ± 0.8 9.9 ± 0.5 £ LOQ
P + cellulose 98.3 ± 0.9 48.4 ± 0.2 15.0 ± 0.9 3.4 ± 0.5 37.7 ± 0.9 17.6 ± 0.2 7.6 ± 0.5
P +  Mg-stearate 98.2 ± 0.9 23.2 ± 0.5 7.1 ± 0.8 £ LOQ 66.0 ± 0.8 47.3 ± 0.6 23.7 ± 0.6
P + talc 98.1 ± 0.9 24.6 ± 0.8 7.1 ± 0.7 £ LOQ 44.7 ± 0.7 23.8 ± 0.3 9.1 ± 0.3
Capsule 90.3 ± 0.3 26.0 ± 0.6 13.0 ± 0.8 – 75.0 ± 0.3 16.3 ± 0.5 –
Powder 91.3 ± 0.8 13.5 ± 0.7 8.2 ± 0.3 – 64.0 ± 0.4 14.5 ± 0.7 –
P – Pancreatin standard
a Mean ± SD, n = 3.
b £ LOQ – 3.3 % of activity.
c Period of storage not evaluated.
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Activity of samples subjected to stress testing
As shown by the data in Table IV, the a-amylase activity was completely maintained 
at pH 9.0 and when subjected to UV light. No significant differences between the sets of 
results were found after applying the t-test at the 95 % confidence level. Further, other 
stress testing conditions were extremely harmful, resulting in activity lower than 2.1 %.
Table III. Activity of protease (%)a in pancreatin samples stored at 40 °C and 75 % RH and 40 °C and 0 % RH 
after different times of incubation
Sample Initial value
With humidity No humidity
1-month 3-months 6-months 1-month 3-months 6-months
Pancreatin 100.0 ± 0.3 8.3 ± 0.5 £LOQ £LOQ £LOQ £LOQ £LOQ
P + citric acid 98.5 ± 0.4 19.8 ± 0.5 £LOQ £LOQ £LOQ £LOQ £LOQ
P + sacharose 99.5 ± 0.7 8.8 ± 0.5 £LOQ £LOQ 2.9 ± 0.6 £LOQ £LOQ
P + mannitol 98.5 ± 0.8 3.4 ± 0.6 £LOQ £LOQ 4.6 ± 0.4 £LOQ £LOQ
P + cellulose 98.5 ± 0.8 8.0 ± 0.5 £LOQ £LOQ 11.0 ± 0.5 £LOQ £LOQ
P +  Mg-stearate 99.0 ± 0.6 2.9 ± 0.6 £LOQ £LOQ 2.9 ± 0.6 £LOQ £LOQ
P + talc 98.3 ± 0.8 5.4 ± 0.5 £LOQ £LOQ 5.4 ± 0.5 £LOQ £LOQ
Capsule 96.3 ± 0.6 77.9 ± 0.9 27.0 ± 0.8 – 91.7 ± 0.3 43.0 ± 0.4 –
Powder 96.4 ± 0.5 48.4 ± 0.4 24.5 ± 0.2 – 82.3 ± 0.7 37.9 ± 0.3 –
Pancreatin – P
a Mean ± SD, n=3.
b £LOQ – 2.6 % of activity.
c Period of storage not evaluated
Table IV. Activity of enzymes in pancreatin samples subjected to stress testing
Sample
a-amylase Lipase Protease
DF a Activity (%)b DF a Activity (%)b DF a Activity (%)b
No stress 100 100.2 ± 0.3 2.5 102.3 ± 0.8 13 100.3 ± 0.4
pH 3.0 – 0.3 ± 0.1 – 15.4 ± 0.4 – 4.1 ± 0.2
pH 9.0 100 101.2 ± 0.9 2.5 94.4 ± 0.5 13 73.1 ± 0.3
pH 11.0 – 0.1 ± 0.02 – 10.9 ± 0.3 – 3.6 ± 0.1
Temperature – 2.1 ± 0.03 – 7.5 ± 0.2 – 1.8 ± 0.1
Oxidation – 0.3 ± 0.02 – 32.2 ± 0.2 13 54.1 ± 0.4
UV light 100 100.2 ± 0.2 – 5.9 ± 0.2 – 2.1 ± 0. 2
a DF – dilution factor.
b without dilution. 
c Mean ± SD, n=3.
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In contrast, significant alterations in lipase activity were observed under all stress 
testing conditions, as indicated by the same statistical parameters. It is important to em-
phasize that lipase is the main enzyme of the pancreatin complex.
 The conditions that best preserved protease activity were pH 9.0 and oxidation. Other 
conditions (acid pH, temperature, UV light and pH 11.0) were extremely harmful to protease 
activity (activities lower than 4.1 % were detected).
For three enzymes, acidic pH, highly basic pH (pH 11.0) and high temperature (70 °C 
for 60 minutes), exposure induced considerable losses in activities. Therefore, attention 
should be paid to the appropriate pH and temperature during the preparation and storage 
of formulations containing pancreatin.
CONCLUSIONS
The a-amylase and protease activities decreased significantly after 1-month storage at 
40 °C and 75 % RH. The protease activity also decreased without humidity; thus, this en-
zyme was most susceptible to degradation. In contrast, lipase showed the highest stability 
(indicated by higher activity levels). The results demonstrate that the proprieties of chemical 
excipients can affect enzyme stability and, consequently, its activity. Sucrose was the ex-
cipient with the best protective effect on α-amylase and lipase in samples stored with humid-
ity. In addition, the enzymatic activity study of the commercial formulation after 3 months 
under both storage conditions showed a substantial decrease in all enzyme activities. This 
result indicates that the efficiency of the commercial formulation is compromised. 
The stress testing data indicate that exposure to pH 3.0, pH 11.0 and temperature in-
duces considerable losses in the activities of the three enzymes. Attention should be paid 
to pH, temperature and humidity during the preparation and storage of pharmaceutical 
pancreatin formulations.
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